MSK and OpenEvidence Announce Two-Way Oncology AI Integration

Memorial Sloan Kettering Cancer Center (MSK) and OpenEvidence have partnered to integrate MSK's OncoKB precision oncology knowledge base into OpenEvidence's AI platform and MSK's Epic EHR system. This two-way integration enables clinicians both at MSK and externally to access expert-curated genomic cancer data alongside patient context for improved clinical decision support in oncology.